Skip to search formSkip to main contentSkip to account menu

cilostamide

Known as: Butanamide, N-cyclohexyl-4-((1,2-dihydro-2-oxo-6-quinolinyl)oxy)-N-methyl-, N-cyclohexyl-N-methyl-4-(1,2-dihydro- 2-oxo-6-quinolyloxy)butyramide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
This editorial refers to ‘Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling… 
2009
2009
Acting through a low-affinity site of the β1-adrenoceptor (β1LAR), CGP12177 causes sinoatrial tachycardia and positive inotropic… 
2008
2008
The present study aimed to analyze detailed morphological and functional characteristics of mouse in vitro matured oocytes after… 
2007
2007
The study reported herein examined the metabolism of 14C‐labeled hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) resulting from a… 
2007
2007
Abstract(-)-Noradrenaline and (-)-CGP12177 activate β1-adrenoceptors through a high (H)- and low-affinity (L) site, respectively… 
2007
2007
AbstractcDNAs encoding two PDE-3 or cyclic GMP-inhibited (cGI) cyclic nucleotide phosphodiesterase (PDE) isoforms, RPDE-3B… 
2006
2006
The cardiostimulant effects of CGP12177, mediated through a β1‐adrenoceptor site with low affinity for (−)‐propranolol, are… 
2002
2002
Phosphodiesterase (PDE) 3s have been characterized in human squamous cell carcinoma KB cells. PDE3 activity was detected in… 
1995
1995
The insulin-like effects of vanadiumin vivo are likely to be achieved at micromolar concentrations. Demonstrated effects of… 
Highly Cited
1985
Highly Cited
1985
Differentiatio of 3T3‐L1 adipocytes, monitored by accumulation of neutral lipid and by increase in α‐giycerophosphate…